1 Introduction
==============

Among next generation sequencing experiments, RNA-seq gene expression profiling stands out as the process of quantifying the transcriptome abundance by counting the RNA fragments (reads) that are aligned on a reference genome ([@btv635-B44]).

In this work, we propose a new method for classifying RNA-seq case--control samples, which is able to compute multiple human readable classification models. We call this method and its software implementation `CAMUR` -- Classifier with Alternative and MUltiple Rule-based models. Although RNA-seq data analysis tools ([@btv635-B17]; [@btv635-B19]) are widely used in case--control studies, the novelty of `CAMUR` consists in the extraction of several alternative and equivalent rule-based models, which represent relevant sets of genes related to the case and control samples. `CAMUR` extracts multiple classification models by adopting a feature elimination technique and by iterating the classification procedure.

`CAMUR` is based on the supervised learning approach (also called *classification* ([@btv635-B24])), the task of inferring a function from labeled training data ([@btv635-B38]). Two data sets are required: (i) the *training set*, which consists of a group of training labeled samples, and hence each sample is a pair consisting of an input object -- that can be a vector of features (attributes) -- and its associated class label; (ii) the *test set*, which is used to classify new samples, after the inferred function is built; the test data may consists of a set of samples, whose class is known, but hidden and used only for verification purpose. Starting from the *training set*, a supervised machine learning algorithm builds the classification model based on the general hypotheses inferred from the features. Then, through this model, the classifier is able either to evaluate the model reliability on the *test set*, or to make predictions on new data. In other words, we can describe the *classification problem* as the process through which a system learns a mapping function (also called model) that assigns a sample to a class ([@btv635-B38]). A classifier is the output of a supervised machine learning algorithm. There are many different state of the art classification algorithms: decision trees ([@btv635-B30]), rule-based ([@btv635-B2]; [@btv635-B3]; [@btv635-B10]; [@btv635-B11]; [@btv635-B12]), ensembles (Bagging, Boosting, Random forest) ([@btv635-B9]), k-Nearest Neighbour ([@btv635-B5]), linear regression ([@btv635-B32]), Naive Bayes ([@btv635-B23]), neural networks ([@btv635-B16]), Perceptrons ([@btv635-B31]), Support Vector Machines (SVM) ([@btv635-B42]) and Relevance Vector Machine (RVM) ([@btv635-B39]). For further details about the supervised learning paradigm and the algorithms the reader may refer to ([@btv635-B46]). Classification algorithms are frequently used in gene expression profiles analysis ([@btv635-B15]; [@btv635-B22]; [@btv635-B27]; [@btv635-B28]; [@btv635-B29]; [@btv635-B33]; [@btv635-B34]; [@btv635-B36]; [@btv635-B40]), in particular for experimental samples classification, i.e. the automatic assignment of each sample to its belonging class (e.g. case--control) after examining its profile. Rule-based classification algorithms are widespread for analyzing gene expression profiles ([@btv635-B8]; [@btv635-B13]; [@btv635-B18]; [@btv635-B37]; [@btv635-B47]; [@btv635-B48]). These types of algorithms produce a classification model composed of logic formulas that provide an immediate relationship between the class and one or more features (genes). The assignment of a given class to each sample is performed by taking into account the satisfiability of the rules. In particular, the classifier uses logic propositional formulas in disjunctive (or conjunctive) normal form ('if then rules') for classifying the given records. Each classification rule (*r*) can be represented as: *r~i~*: Antecedent → Consequent (e.g. $\left. feature_{1} > 0.7 \land feature_{2} < 0.4 \vee feature_{3} > 0.9\Rightarrow control \right.$). The antecedent contains a conjunction of attribute tests, each one known as literal (e.g. $feature_{1} > 0.7$), the consequent represents the covered class (e.g. *control*). Examples of rule-based classifiers are RIPPER ([@btv635-B3]), LSQUARE ([@btv635-B10]), LAD ([@btv635-B2]), RIDOR ([@btv635-B12]) and PART ([@btv635-B11]).

We chose to analyze RNA-seq data with rule-based algorithms, because of their human readability, i.e. the investigator is provided with a list of meaningful features (genes) that appear in the rules. Specifically, among the state of the art classifiers we implement our method relying on the *Repeated Incremental Pruning to Produce Error Reduction* -- RIPPER algorithm, because it is a robust and effective rule-based approach that provides reliable case--control models in terms of classification rates and computational performances ([@btv635-B20]). In RNA-seq, rule-based algorithms may provide a low number of features (genes) into the resulting rules. For example, in a binary classification problem the classifier can build a model made of only two rules, with two or three features (e.g. $\left. gene_{1} > 0.7 \land gene_{2} < 0.4 \vee gene_{3} > 0.9\Rightarrow control \right.$). Although this fact does not affect the classification performances, many other features that have discriminant power may not be present in the classification model. Therefore, our aim is to extract a comprehensive amount of knowledge from the analyzed data composed of equivalent and alternative classification models (i.e. rules). For example, to maximize the knowledge extraction in RNA-seq samples classification, we aim to detect all the genes that are implied with the analyzed disease, i.e. the discriminant genes that appear in alternative classification models. For extracting multiple classification solutions, one approach is presented in ([@btv635-B6]), where the authors found 352 different three-gene combinations providing a 100% correct classification to the Leukemia gene expression profile data available at ([@btv635-B15]), by extending a genetic algorithm ([@btv635-B7]) into a multi-objectives evolutionary one that finds multiple and multimodal solutions in one single run ([@btv635-B25]). Those are defined as solutions that have identical objective values, but they differ in their format. Furthermore, another classification approach is presented in ([@btv635-B14]) and relies on a *feature elimination method*, which consists of choosing features and then, removing those that do not match an assumption criteria. The deletion is performed in order to obtain a smaller set of features that can perform as well as the larger one, and hence the computational overhead is reduced. However, the authors aim is not to extract alternative and equivalent classification models. Conversely, we aim to obtain more than one reliable classification model by performing an *iterative feature elimination* without implementing an optimization method.

2 Materials and methods
=======================

First, the terminology adopted in the paper is introduced. We collect *n* samples, each one described by its *m* features (gene expression profiles) and labeled with a class (condition), e.g. normal -- tumoral (We adopt The Cancer Genome Atlas terminology (i.e. normal -- tumoral), where normal corresponds to a healthy sample (control) and tumoral to a diseased one (case).). The *i*th sample of the data set is represented by the vector $g_{i} = (g_{i1},g_{i2},\ldots,g_{im},g_{ic})$, where $g_{ij} \in \mathbb{R},\, i = 1,\ldots,n,\, j = 1,\ldots,m$ and $g_{ic} \in \left\{ normal,tumoral \right\}$. Therefore, the vectors $g_{1},g_{2},\cdots,g_{n}$ compose the data matrix, whose rows correspond to the samples and whose columns to their features. The reader may refer to [Table 1](#btv635-T1){ref-type="table"} for an example.

###### 

Example of the breast cancer RNA-seq data matrix extracted from The Cancer Genome Atlas (TCGA)

  SampleID   ANO8   C1orf27   TRPM6   $\cdots$   Class
  ---------- ------ --------- ------- ---------- ---------------
  A8-A09D    2.64   5.42      0.38    $\cdots$   Breast cancer
  BH-A0DH    1.46   6.47      0.76    $\cdots$   Normal
  GM-A2DC    2.22   22.50     0.53    $\cdots$   Breast cancer
  GM-A2D9    3.13   14.21     0.61    $\cdots$   Breast cancer
  $\cdots$   ⋯      ⋯         ⋯       $\cdots$   $\cdots$
  GM-A2DB    3.86   5.15      0.59    $\cdots$   Breast cancer

The rows correspond to the samples and the columns to their features (gene expression profiles). The cells contain the gene expression measure Reads Per Kilobase per Million mapped reads (RPKM) explained in Section 2.3.

2.1 CAMUR: classifier with alternative and multiple rule-based models
---------------------------------------------------------------------

In this section, we describe `CAMUR`, a method and a software designed to find alternative and equivalent solutions for a classification problem. `CAMUR` is based on: In brief, the method iteratively computes a rule-based classification model through the supervised RIPPER algorithm, calculates the power set (or a partial combination) of the features present in the rules, iteratively eliminates those combinations from the data set, and performs again the classification procedure until a stopping criterion is verified.

1.  a rule-based classifier (i.e. in this work RIPPER);

2.  an *iterative feature elimination* technique;

3.  a repeated classification procedure;

4.  an *ad-hoc* storage structure for the classification rules (`CAMUR` database).

In greater details, `CAMUR` executes at first the RIPPER algorithm, which extracts from a training set the classification model that contains rules with a number of features (i.e. genes) and their values (i.e. quantification levels). *Accuracy* and *F* -- *measure* (see Eq. [1](#btv635-M1){ref-type="disp-formula"}) are used on a test set to evaluate the extracted classification model. Then, `CAMUR` stores the classification model and the results into a database and extracts the features from the generated model. We call this set of features *S~t~* (where *t* is the current iteration) and we define the list where those features are memorized as *FL.* After that, `CAMUR` computes the power set of the features *P~t~* by storing all the combinations into the main memory. In the following, we refer to the Original Data Set of features as *ODS.* Starting from *P~t~*, the software performs a feature elimination by deleting from *ODS* one combination of features at time (i.e. an item of the power set) and executes the RIPPER classification algorithm on the new data set $(ODS - p_{tj})$ with $p_{tj} \in P_{t}$ (*p~tj~* is the *j*th element of *P~t~* and $j = 1,\ldots,|P_{t}|$). All the results of the elimination and classification steps are memorized in the `CAMUR` database. These operations are iterated on the new generated data sets $(ODS - p_{tj})$ with $p_{tj} \neq p_{kl}$ where *k* \< *t* and $l = 1,\ldots,|P_{k}|$, updating *FL* at each iteration. We highlight that the power set ($P_{t + 1}$) generation on the new feature sets $S_{t + 1}$ is performed by not taking into account duplicate combinations that occurred in previous power sets *P~k~* with $k \in \lbrack 1,t + 1)$. `CAMUR` terminates the execution when one of the following conditions is satisfied: At the end of this procedure, we have a collection of alternative classification models composed of several features that are able to distinguish the samples with high reliability. For evaluating the classification models and consequently to terminate the procedure, we adopt the *accuracy* and the *F* -- *measure* (refer to Eq. [1](#btv635-M1){ref-type="disp-formula"}). Given *True Positives (TP)*, objects of that class recognized in the same class; *False Positives (FP)*, objects not belonging to that class recognized in that class; *True Negatives (TN)*, objects not belonging to that class and not recognized in that class; *False Negatives (FN)*, objects belonging to that class and not recognized in that class, the measures are defined as follows: $$F - measure = \frac{2P \cdot R}{P + R};Accuracy = \frac{TP + TN}{TP + TN + FP + FN}$$ where $P = \frac{TP}{TP + FP}$ is the *Precision* and $R = \frac{TP}{TP + FN}$ is the *Recall.*

1.  the reliability of the classification models is below a given threshold, e.g. *F* -- *measure* (see Eq. [1](#btv635-M1){ref-type="disp-formula"}) lower than 0.85;

2.  the list of features *FL* has been completely processed;

3.  the maximum number of iterations has been reached.

In the following, we provide an execution example of the algorithm. Given a data set composed of 10 features (genes) and 10 samples -- 5 tumoral and 5 normal --, `CAMUR` extracts through the first execution of RIPPER a classification model composed of a set of rules (e.g. $\left. gene_{1} > 0.7 \land gene_{2} < 0.4 \vee gene_{3} > 0.9\Rightarrow normal \right.$). The rules contain a set of three features $S_{1} = \left\{ gene_{1} \right.$, *gene*~2~, $\left. gene_{3} \right\}$ which is stored in the features list *FL.* Starting from *S*~1~ the power set (except the empty set) *P*~1~ is computed: $P_{1} = \left\{ \left\{ gene_{1} \right\},\,\left\{ gene_{2} \right\},\left\{ gene_{3} \right\},\,\left\{ gene_{1},gene_{2} \right\},\,\left\{ gene_{1},gene_{3} \right\},\,\left\{ gene_{2},gene_{3} \right\},\,\left\{ gene_{1},gene_{2},gene_{3} \right\} \right\}$. The first item of the power set is eliminated from the data set and the classification procedure is performed, which provides a new set of features, e.g. $S_{2} = \left\{ gene_{3},\, gene_{4} \right\}$. The first power set *P*~1~ is completely processed, generating a number of feature sets *S*, which are stored in *FL.* After the processing of *P*~1~, the power set *P*~2~ from *S*~2~ is computed and the classification is performed. The algorithm continues until one of the stopping criteria is verified. To speed up the procedure, it is worth noting that the next power set is computed and processed only when the current power set has been completely examined.

The computational time depends on: (i) the size of the power sets, which are related to the size of the feature sets *S~i~* -- if the cardinality of the feature set is equal to *m* ($m = |S_{i}|$), then the power set generation requires in the worst-case $O(2^{m})$; (ii) the worst-case complexity of RIPPER, i.e. $O(nlog^{2}n)$ with *n* number of samples in the training set. Therefore, the total complexity of `CAMUR` is $O(2^{m}nlog^{2}n)$. We highlight that usually the number of features present in rule-based classification models is limited, especially when dealing with two-class classification problems, as case--control studies.

Additionally, we investigate the possibility to iterate the feature elimination in different ways, and hence our algorithm can be executed as follows: $\mathtt{loose}\,\mathtt{mode},\,\mathtt{strict}\,\mathtt{mode},\,\mathtt{double}\,\mathtt{mode}$.

In the `loose` feature elimination mode, the algorithm performs a combined *iterative feature elimination.* As above-mentioned, this execution mode takes the model and the results from the first classification and builds the power set of the found features, whose combinations are iteratively eliminated from the data set. A classification step follows each elimination of the feature combinations. The new extracted features that are present in the current model are added to the features list *FL* and are going to be processed in the next iterations.

In the `strict` feature elimination mode, the algorithm performs a single *iterative feature elimination.* First, a classification with the RIPPER algorithm is performed, the features that appear into the rules are extracted, and then eliminated one by one. The classification is iterated after each elimination on the resulting data set. In contrast to the $\mathtt{loose}\,\mathtt{mode}$, once a feature is eliminated, it is never inserted again into the data set. Referring to the example given above, in the $\mathtt{strict}\,\mathtt{mode}$ the execution is straightforward. Starting from the above-mentioned feature set *S*~1~, `CAMUR` proceeds with the elimination of *gene*~1~ from the original data set *ODS* and performs the classification on the new data set, obtaining $S_{2} = \left\{ gene_{3},\, gene_{4} \right\}$. Then, it eliminates *gene*~2~ from $ODS - \left\{ gene_{1} \right\}$ and performs the classification again, obtaining *S*~3~. It finishes to process *S*~1~, and then all the other ones contained in *FL* if a proper stopping criteria is satisfied.

The $\mathtt{strict}\,\mathtt{mode}$ is faster than the $\mathtt{loose}\,\mathtt{mode}$, this can be explained by the two main differences: (i) the $\mathtt{strict}\,\mathtt{mode}$ does not compute the power set, so there are less classification procedures to run; (ii) on each classification run one discriminating feature is eliminated from the original data matrix. Therefore, the accuracy of the models may decrease faster. Conversely, the $\mathtt{loose}\,\mathtt{mode}$ extracts more knowledge but is slower, because the computed power set has a $2^{m}$ sets and for each one `CAMUR` runs the classification algorithm again.

Finally, it is possible to execute both the `strict` and the $\mathtt{loose}\,\mathtt{mode}$ through the $\mathtt{double}\,\mathtt{mode}$. This execution mode performs first the `strict` and then the $\mathtt{loose}\,\mathtt{mode}$, storing all the models and results into the `CAMUR` database.

2.2 The CAMUR software package
------------------------------

The `CAMUR` software package is composed of two distinct parts: The MSE corresponds to the implementation of the `CAMUR` algorithm described in Section 2.1. In brief, it performs the iterative classification and feature elimination procedures and fills the database with the results and models.

-   *Multiple Solutions Extractor* (MSE);

-   *Multiple Solutions Analyzer* (MSA).

The MSE is organized in following modules:

-   `InputManager`, which manages the user interactions and the input;

-   `CamurLauncher`, which executes the iterative `CAMUR` classification algorithm;

-   `DataElaborator`, which is responsible for the data set to classify and performs feature elimination;

-   `FeaturesManager`, which manages the feature lists and power sets;

-   `ResultsElaborator`, which processes the classification results and models;

-   `DataAccessObject(DAO)`, which has the responsibility to communicate with the database.

The component diagram of the software is shown in [Figure 1](#btv635-F1){ref-type="fig"}.

![Component diagram of the MSE part of the `CAMUR` software package](btv635f1p){#btv635-F1}

The workflow of the software is as follows: the `InputManager` processes the user input data (data matrix) and the parameters (e.g. maximum number of iterations, execution mode), input data are taken by the `CamurLauncher` and managed through the `DataElaborator`. Then, `CamurLauncher` performs the iterative classification by managing the feature eliminations and combinations through the `FeaturesManager`. The `ResultsElaborator` stores the classification models and results in the database with the aid of the `DataAccessObject(DAO)`.

On the other hand, the MSA is a support tool dedicated to the analysis and interpretation of the obtained results, it extracts knowledge from the database by running predefined queries. The following queries have been included in the software:

1.  Q1 **Genes list**: *Which are all the genes that are able to distinguish tumoral samples from normal ones in a given RNA-seq experiment? And how many times do they occur in all the obtained classification models?*

2.  In this query, we extract the list of genes and their occurrences in all the extracted rule-based classification models.

3.  Q2 **Literals and conjunctions list**: *Which are the most relevant literals (e.g*.**$gene_{1} > 0.7$*)and conjunctions (e.g*.**$gene_{1} > 0.7 \land gene_{2} < 0.4$*)and their related correctly classified instances?*

4.  Through this query, we identify the conjunctions of one or more rule literals (e.g. $gene_{1} > 0.7$) optionally linked with a logic $\land$. For each conjunction, we report: (i) the number of correctly (incorrectly) classified instances; (ii) the percentage of correctly (incorrectly) classified instances.

5.  Q3 **Rules list**: *Which are the classification rules and how is their reliability?*

6.  In this query, we extract the rule disjunctions (i.e. conjunctions linked with a logic $\vee$), their measures of reliability, i.e. *F* -- *measure*, *accuracy* (refer to Eq. [1](#btv635-M1){ref-type="disp-formula"} of Section 2.1).

7.  Q4 **Literals statistic**: *Which are the literals (e.g*.**$gene_{1} > 0.7$*)that more frequently occur within a specific range?*

8.  Such a query provides the gene name, the literal operator (e.g. \<, \>), its minimum and maximum value, the values average ($\overline{\mu}$) and their standard deviation (*σ*), the number of occurrences of each literal with the same operator, and finally the *coefficient of variation* measure defined as: $\frac{\sigma}{\overline{\mu}}$.

9.  Q5 **Gene pairs**: *Which are all the pairs of genes that appear within a same rule and how many are their occurrences?*

10. This query extracts all the couples of genes that are present in a same rule and counts how many times these two genes appear together.

The MSA is organized in the following modules: The MSA software is released with a graphic interface, which enables to choose a predefined query and to set additional parameters. It provides the real knowledge in terms of gene lists, gene interactions, expression thresholds, classification results and models. A screenshot of the graphic interface is depicted in [Figure 2](#btv635-F2){ref-type="fig"}. The `CAMUR` software package composed of the MSE and the MSA and described above is implemented in JAVA for linux, windows and mac-os operating systems under a GPL license and is available at dmb.iasi.cnr.it/camur.php. A comprehensive user guide is provided as [supplementary data S1](#sup1){ref-type="supplementary-material"}.

-   $\mathtt{GraphicUserInterface}$, which is responsible for user interactions and for showing the results of the queries;

-   $\mathtt{QueryManager}$, which executes the query and collects the results;

-   $\mathtt{QueryBuilder}$, which builds a query according to the user input;

-   $\mathtt{QueryProcessor}$, which processes the query by retrieving all the information from the database;

-   $\mathtt{DataAccessObject}(\mathtt{DAO})$, which has the responsibility to communicate with the database.

![Screenshot of the MSA part of the `CAMUR` software package: it displays the initial parameters configuration available to the user](btv635f2p){#btv635-F2}

### CAMUR database

`CAMUR` stores the classification models and the results of the procedure into an *ad-hoc* storage structure, called `CAMUR` database. It permits the execution of the MSA queries for knowledge extraction. This database has a total of 16 relationships and 13 entities, the main ones are described below: `CAMUR` database is implemented with the open source software MySql ([www.mysql.com](http://www.mysql.com)).

-   $\mathtt{Run}$, which contains information about the execution of the MSE;

-   $\mathtt{Experiment}$, which represents an execution of the classification procedure and stores its results;

-   $\mathtt{Rule}$, which consists of the whole set of disjunctions that predict a class;

-   $\mathtt{LiteralSet}$ that is a set of conjunctions;

-   $\mathtt{Literal}$ that is composed by a *feature*, an operator (i.e. \>, \<, $\geq ,\, \leq , = , \neq$) and a value;

-   $\mathtt{FoundFeaturesSet}$ that represents the set of features extracted from the rules;

-   $\mathtt{RemovedFeaturesSet}$ that is the set of features eliminated before an experiment execution.

2.3 Experimental data
---------------------

In this work, we test our method on RNA-seq experimental data extracted from *The Cancer Genome Atlas* (TCGA) ([@btv635-B45]). Additionally, we validate our method on non-TCGA data.

The Cancer Genome Atlas is a project that aims to offer a comprehensive overview of genomic changes involved in human cancer. A data portal available at [www.tcga.org](http://www.tcga.org) offers access to a large number of genomic and clinical experiments related to more than 10 000 patients affected by 33 different tumor types. In addition, it provides a collection of diverse metadata (e.g. clinical health records) associated to the patients. The TCGA portal contains clinical information, genomic characterization data, and high level sequence analysis of the tumor genomes.

We extract RNA-seq experiment data related to Breast (BRCA), Head and Neck (HNSC) and Stomach (STAD) Cancers. The data set characteristics are summarized in [Table 2](#btv635-T2){ref-type="table"}. For each data set, we take into account the Reads Per Kilobase per Million mapped reads (RPKM) value of each gene expression measure ([@btv635-B26]), which normalizes the gene raw counts by considering the length of the gene and the total number of the fragments: $$RPKM = \frac{R}{N_{r} \cdot L} \cdot 10^{9}$$ where *R* is the number of mapped reads onto the gene exons, *N~r~* is the total number of mapped reads, and *L* is the feature length that corresponds to the number of nucleotides of the exonic region of the gene. For each tumor, we build a unique matrix of RPKM values, where the rows correspond to the samples, the columns to genes, and the cells to the RPKM values. The matrix given as input to `CAMUR` is similar to that one depicted in [Table 1](#btv635-T1){ref-type="table"} of Section 2. An ad-hoc software 'Tcga2Camur' that converts the TCGA RNA-seq data sets into the CAMUR data matrix has been developed and is available at dmb.iasi.cnr.it/camur.php.

###### 

Summary of the analyzed data sets

  Cancer   Tissues   Tumoral   Normal   Genes   \[MB\]
  -------- --------- --------- -------- ------- --------
  BRCA     884       783       101      20532   292
  HNSC     295       264       31       20532   92
  STAD     271       238       33       29699   56

The three data sets are extracted from The Cancer Genome Atlas. The numbers refer to the sequenced tissues, belonging to tumoral and normal classes (first three columns). It is worth noting that for each data set the number of analyzed samples corresponds to the number of tumoral tissues (third column). The last two columns refer to the number of genes and the size of the three data sets.

It is worth noting that `CAMUR` can be applied also to gene expression data processed by other normalization methods, such as RSEM (RNA-seq by Expectation Maximixation) ([@btv635-B21]). RSEM guesses how many ambiguously mapping reads belong to a transcript/gene (i.e. *raw count* value of the TCGA data) and estimates the frequency of the gene/transcript among the sequenced transcripts (i.e. *scaled estimate* value of the TCGA data). RSEM provides an accurate transcript quantification without requiring a reference genome. In particular, we test `CAMUR` on RNA-seq data of BRCA extracted from TCGA and normalized with the RSEM method.

Moreover, we validate `CAMUR` on a non-TCGA data set: the Wilms Tumor (WT) ([@btv635-B43]) among the Kidney Tumors of the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) project.

Finally, we evaluate `CAMUR` classification models on non-TCGA BRCA data sets downloaded from Gene Expression Omnibus (GEO) with accession numbers GSE56022 and GSM1308330.

3 Results and discussion
========================

In this section, we provide an overview of the extracted knowledge from the analyzed data, including statistics of the performed experiments, and a more specific discussion of the obtained results.

We analyzed the TCGA data sets of Breast, Head and Neck, and Stomach Cancers with both the `loose` and the $\mathtt{strict}\,\mathtt{mode}$ of `CAMUR`. `CAMUR` ran a total of 1486 classification procedures with a percentage split sampling schema (80% training, 20% test) ([@btv635-B38]). The classification procedures stopped either for the decreasing of the classification performances, or because the maximum number of iterations was reached. On average, the obtained precision, recall and *F* -- *measure* values are greater than 99%. Within the generated rules `CAMUR` found 904 different genes, each gene is found on average 23.34 times (the occurrences of each gene range from 1 to 900). `CAMUR` computed 8182 sets of combinations (736 in $\mathtt{strict}\,\mathtt{mode}$ and 7446 in $\mathtt{loose}\,\mathtt{mode}$), each one composed of 1--7 genes (average 2.57). The amount of removed sets is 1480 (364 in $\mathtt{strict}\,\mathtt{mode}$, 1116 in $\mathtt{loose}\,\mathtt{mode}$), which represent the removed genes from a data set. The number of genes within these sets is on average 2.025 and the values range from 1 to 6.

The `CAMUR` analysis (`strict` and $\mathtt{loose}\,\mathtt{mode}$) on the Breast, the Head and Neck and the Stomach Cancer data set provides 513, 218 and 272 different genes, respectively. The corresponding gene expressions allow the scientist to distinguish normal samples from tumoral ones and they are potential markers for the diseases.

The total amount of gene pairs identified in all rule sets are 20139, 610 and 272, for the Breast, the Head and Neck and the Stomach Cancer, respectively. Among those genes pairs, 2212 for Breast, 256 for Head and Neck, 137 for Stomach Cancer have been found into rule sets containing exactly a pair of genes.

We show the execution times of `CAMUR` in [Table 3](#btv635-T3){ref-type="table"}. It is worth noting that the processing of the Breast Cancer data set requires longer time, because of the large number of samples and of the rules size.

###### 

`CAMUR` execution times

  Cancer   Total time \[h\]   Loose mode time \[h\]   Strict mode time \[h\]
  -------- ------------------ ----------------------- ------------------------
  BRCA     6 h:56 m           6 h:17 m                0 h:39 m
  HNSC     0 h:33 m           0 h:26 m                0 h:7 m
  STAD     0 h:27 m           0 h:17 m                0 h:10 m

The execution times for Breast (BRCA), Head and Neck (HNSC), Stomach (STAD) Cancer. Times are reported in hours.

In the following, we report the extracted knowledge related to the Breast cancer by discussing the obtained results of each query described in Section 2.1. The results related to the other data sets can be found in [supplementary data S2](#sup1){ref-type="supplementary-material"}.

With query 1 (*features list*), we extract 383 genes and their occurrences found by `CAMUR` during the classification experiments. We show in [Table 4](#btv635-T4){ref-type="table"} an example of the results of this query.

###### 

A portion from the output results of the 'list of attributes' query

  Gene              Occurrences
  ----------------- -------------
  ADAMTS5$|$11096   109
  MMP11$|$4320      102
  FIGF$|$2277       84
  SDPR$|$8436       82
  COL10A1$|$1300    51
  $\cdots$          $\cdots$

The extracted genes are sorted by their occurrences, which may point to a relation with the disease. In [Table 5](#btv635-T5){ref-type="table"}, we provide a list of the most frequent 12 genes extracted during the execution of `CAMUR`.

###### 

List of the most common 12 genes (row-wise) extracted by `CAMUR`

  ------------------ ------------------ ----------------
  MMP11$|$4320       ADAMTS5$|$11096    SDPR$|$8436
  FIGF$|$2277        CGB7$|$94027       COL10A1$|$1300
  TMEM220$|$388335   ARHGAP20$|$57569   SPRY2$|$10253
  ACSM5$|$54988      FXYD1$|$5348       EPDR1$|$54749
  ------------------ ------------------ ----------------

With query 2 (*conjunctions list*), we extract 1708 conjunctions and the values of the correctly (incorrectly) classified samples. For example, we extracted '(SDPR$|$8436 $\geq$ 11.6) $\land$ (ANXA1$|$301 $\geq$ 161.3) $\Rightarrow$*Normal*' that classified correctly all the 87 instances of the test set. Query 3 (*disjunctions list*) extracts 1564 classification rules, e.g. '(SPRY2$|$10253 $\geq$ 14.4) $\land$ (C20orf160$|$140706 $\geq$ 1.8) $\vee$ (COL10A1$|$1300 $\leq$ 0.7) $\land$ (AASS$|$10157 $\geq$ 1.6) $\Rightarrow$*Normal*', which provides an accuracy of 100%. Through query 4 (*literal statistics*), we extract 397 most frequent genes and we may capture if they show comparable expression values. An interesting example for the output interpretation of query 3 in Breast Cancer is: gene TMEM220$|$388335 occurs 33 times, and its attribute value is $\geq 2.6 \pm 0.007$, and hence provides a strong and stable signal. Query 5 (*pairs of features*) displays 2212 pairs of genes and a counter of how many times they appear together. The pairs that appear mostly are depicted in [Table 6](#btv635-T6){ref-type="table"}. Additionally, it is worth noting that the user can define personalized queries and run them directly on the database.

###### 

An example of the output for query 5

  Gene 1          Gene 2            Occurrences
  --------------- ----------------- -------------
  FIGF$|$2277     MMP11$|$4320      100
  CGB7$|$94027    ADAMTS5$|$11096   73
  SDPR$|$8436     ANXA1$|$301       37
  EPDR1$|$54749   MMP11$|$4320      34
  $\cdots$        $\cdots$          $\cdots$

Furthermore, among the gene lists extracted by `CAMUR`, we found 3 genes (i.e. ACOT7$|$11332, ADAR$|$103 and GLT25D1$|$79709) shared by Breast, Head and Neck and Stomach Cancer set: in panel a of [Figure 3](#btv635-F3){ref-type="fig"} we show all the overlaps among the three sets of genes through an Eulero-Venn diagram. A preliminary functional analysis on the human protein atlas ([@btv635-B41]) confirms the relation of those genes with the three above-mentioned cancer types.

![Eulero-Venn diagram of the `CAMUR` gene lists for BRCA, HNSC and STAD: (a) diagram of overlapped genes extracted by `CAMUR`; (b) diagram of the overlapped genes between the `CAMUR` gene lists and the differential expressed ones](btv635f3p){#btv635-F3}

In order to strengthen `CAMUR`, we performed the following tests. Since we have not found other state of the art classification algorithms that implement multiple models extraction, a direct comparison of our method is not feasible. Therefore, we compared `CAMUR` with respect to a standard wide-spread technique that relies on the differential expression analysis ([@btv635-B35]) and that provides a list of statistically significant genes related to case--control samples, by applying Benjamini-Hochberg correction ([@btv635-B1]) to estimate a False Discovery Rate (FDR)-adjusted p-value. We extracted a list of 1851, 787, 1296 genes with a *P*-value $\leq 0.001$ for BRCA, HNSC and STAD, respectively. The above-mentioned lists were compared with those extracted by `CAMUR`. We found 36 for BRCA, 11 for HNSC, 99 for STAD genes that are shared in both lists (panel b of [Fig. 3](#btv635-F3){ref-type="fig"}). The lists of shared genes are available as [supplementary data S3](#sup1){ref-type="supplementary-material"}. It is worth noting that the size of the lists extracted by `CAMUR` is smaller, and hence our approach allows to focus on few core genes related to the investigated disease. Additionally, most of those genes are not selected by the differential expression analysis enhancing the novelty of our approach.

Additionally, we ran several tests to validate `CAMUR`, its classification models, and its performances. The detailed results are available as [supplementary data S4](#sup1){ref-type="supplementary-material"}. First, we randomly selected ten BRCA rules extracted by `CAMUR` and verified them on two external breast cancer RNA-seq data sets of GEO (GSE56022 and GSM1308330). Most of the rules succeed in the identification of the diseased samples confirming the validity of our method: 9 out of 10 correctly cover the GSM1308330 samples, 7 out of 10 the GSE56022 ones (but we remark that 2 of the not successful rules cannot be applied because a gene is not present in the data set). Second, we tested `CAMUR` on a non-TCGA data set: the Wilms Tumor (WT) ([@btv635-B43]) of the (TARGET) project. It consists of 94 tissues (82 tumoral, 12 normal) and 58450 mRNA gene expression values normalized with the RPKM method. `CAMUR` performed 320 runs (212 `loose` and 108 in $\mathtt{strict}\,\mathtt{mode}$) finding 231 different genes with an average *F-measure* of 0.98. Third, we validated `CAMUR` on RNA-seq data of BRCA normalized with the RSEM method. `CAMUR` executed 2048 classification experiments (1895 `loose` and 153 in $\mathtt{strict}\,\mathtt{mode}$) and extracted 986 different genes with an average *F-measure* of 0.99. Finally, we performed a comparative analysis of `CAMUR` with respect to the SVM classifier by computing the same number of classification runs: both methods reached high reliable results (average *F-measure* of 0.97 for SVM, 0.99 for `CAMUR`) on all data sets. We remark that SVM outputs just a single classification model that cannot be easily interpreted by human experts.

4 Conclusion
============

In this work, we presented `CAMUR`, a new method for multiple solutions extraction in rule-based classification problems. We showed that the amount of knowledge extracted by our algorithm is higher than a standard supervised classification. We described the two parts of `CAMUR` software package: MSE that performs the classification procedure and MSA that analyzes the obtained results. Additionally, we designed and developed a database for an effective and comprehensive knowledge extraction. We proved the efficacy of our algorithm on large sets of RNA-seq data, focusing on Breast, Head and Neck and Stomach Cancer from TCGA, and validating it on external data sets from TARGET and GEO. To conclude, `CAMUR` results as a reliable technique for solving classification problems by extracting many alternative and equally accurate solutions.

In future, we intend to test our method on other RNA-seq data sets in order to build a large knowledge repository of classification models related to a particular disease. The extracted genes may then be analyzed by domain experts with functional and enrichment analyses ([@btv635-B4]). It would be also interesting to perform a simulation study for evaluating the performance of CAMUR under different scenarios in a quantitative manner. Additionally, we plan to integrate in our software other rule-based classifiers, as well as to enrich the software with new functions and higher performances. Finally, we plan to extend the analysis to other biological data sets as sequences classification, e.g. DNA-Barcoding.

Supplementary Material
======================

###### 

Click here for additional data file.
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